Characterization of Early Markers of Choroidal Neovascularization

NCT00801541 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2015-03-19

No results posted yet for this study

Summary

To this study and identify the sequence of alterations occurring in the chorioretinal interface during progression of AMD from "dry" AMD to sight-threatening chorioretinal neovascularization (CNV).

Conditions

  • Age-related Macular Degeneration

Sponsors & Collaborators

  • Association for Innovation and Biomedical Research on Light and Image

    lead OTHER

Principal Investigators

  • José Cunha-Vaz, MD PhD · Association for Innovation and Biomedical Research on Light and Image

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-12-31
Primary Completion
2008-12-31
Completion
2014-06-30

Countries

  • Portugal

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00801541 on ClinicalTrials.gov